ArticleJournal of translational medicine2024

MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combination therapy in hepatocellular carcinoma.

Guangbo Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.